COST-EFFECTIVENESS OF VARIOUS COMBINATIONS OF HUMAN PAPILLOMAVIRUS (HPV)-BASED PRIMARY SCREENING TESTING, INCLUDING GENOTYPING FOR HPV 16/18, FOR CERVICAL CANCER SCREENING IN MEXICO

被引：0
|
作者：
Corro, A. [1 ]
Ramirez, A. [1 ]
Williams, E. [2 ]
Huang, J. [3 ]
Souza, F. H. [4 ]
机构：
[1] Roche Diagnost, Mexico City, DF, Mexico
[2] Xcenda, Palm Harbor, FL USA
[3] Roche Mol Diagnost, Pleasanton, CA USA
[4] Roche Diagnost, Sao Paulo, Brazil
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1947
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A671 / A671
页数：1
相关论文
共 50 条
  • [41] Cervical Cancer Screening in Partly HPV Vaccinated Cohorts - A Cost-Effectiveness Analysis
    Naber, Steffie K.
    Matthijsse, Suzette M.
    Rozemeijer, Kirsten
    Penning, Corine
    de Kok, Inge M. C. M.
    van Ballegooijen, Marjolein
    PLOS ONE, 2016, 11 (01):
  • [42] Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screening
    Bidus, Michael A.
    Maxwell, G. Larry
    Kulasingam, Shalini
    Rose, G. Scott
    Elkas, John C.
    Chernofsky, Mildred
    Myers, Evan R.
    OBSTETRICS AND GYNECOLOGY, 2006, 107 (05): : 997 - 1005
  • [43] ARTISTIC: a randomised trial of-human-papillomavirus (HPV) testing in primary cervical screening
    Kitchener, H. C.
    Almonte, M.
    Gilham, C.
    Dowie, R.
    Stoykova, B.
    Sargent, A.
    Roberts, C.
    Desai, M.
    Peto, J.
    HEALTH TECHNOLOGY ASSESSMENT, 2009, 13 (51) : 1 - +
  • [44] Clinical impact and cost-effectiveness of primary cytology versus human papillomavirus testing for cervical cancer screening in England
    Bains, Irenjeet
    Choi, Yoon Hong
    Soldan, Kate
    Jit, Mark
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (04) : 669 - 675
  • [45] A Systematic Review on Cost-Effectiveness Studies Evaluating HPV Self-Testing for Cervical Cancer Screening
    Hallsson, Lara Run
    Haaf, Leonie Heloiese
    Hillemanns, Peter
    Jentschke, Matthias
    Siebert, Uwe
    Sroczynski, Gaby
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP217 - NP219
  • [46] Clinical efficacy of primary human papillomavirus (HPV) screening with partial genotyping for HPV-16 and HPV-18 subtypes in women from 25 years old
    Ang, Joella Xiaohong
    Lee, Wai Yen
    Tay, Sun Kuie
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2023, 52 (05) : 259 - 267
  • [47] The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador
    Campos, Nicole G.
    Maza, Mauricio
    Alfaro, Karla
    Gage, Julia C.
    Castle, Philip E.
    Felix, Juan C.
    Cremer, Miriam L.
    Kim, Jane J.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (04) : 893 - 902
  • [48] Cost-effectiveness of HPV-based cervical cancer screening in the public health system in Nicaragua
    Campos, Nicole G.
    Mvundura, Mercy
    Jeronimo, Jose
    Holme, Francesca
    Vodicka, Elisabeth
    Jane, J. Kim
    BMJ OPEN, 2017, 7 (06):
  • [49] Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening
    Chatzistamatiou, Kimon
    Moysiadis, Theodoros
    Moschaki, Viktoria
    Panteleris, Nikolaos
    Agorastos, Theodoros
    GYNECOLOGIC ONCOLOGY, 2016, 142 (01) : 120 - 127
  • [50] Maximising the cost-effectiveness of human papillomavirus testing for cervical screening in the context of routine HPV vaccination in Hong Kong: abridged secondary publication
    Leung, S. M. K.
    Wu, J.
    Chan, K. K. L.
    Jit, M.
    HONG KONG MEDICAL JOURNAL, 2023, 29 (04) : 11 - 15
12345